|Day Low/High||129.20 / 132.80|
|52 Wk Low/High||118.62 / 148.99|
Jim discusses his thoughts on if a 'Santa-Clause' rally is possible, tomorrow's Fed announcement, yesterday's interview with JNJ CEO Alex Gorsky on 'Mad Money', and much more!
Jim Cramer breaks down Real Money's stock of the day, Oracle, and his interview with Johnson & Johnson's CEO.
U.S. stock futures rise on Tuesday, rebounding slightly from Monday's sharp selloff; global shares sink in the face of slowing economic growth; Oracle spikes after earnings and revenue top analysts' forecasts; T-Mobile and Sprint merger moves another step closer to completion.
Jim Cramer says the market won't be able to find a bottom until several key conditions are met, most notably what the Fed is going to do.
Here's what you should know about the band-aid company.
Johnson & Johnson board sees opportunity in shares beaten down after reports the company covered up knowledge of asbestos in its talcum powder products.
Putting J&J stock's selloff in a graphic illustrates the market's swift and violent reaction to the Reuters report.
Johnson & Johnson, Goldman Sachs and Jack in the Box are some of the top stories on TheStreet.
There are two sides to every coin. Is the market oversold? One of TheStreet's top editors tells investors how to think.
Stocks fall sharply Monday as investors remain cautious over the health of the world economy.
Shares continue to fall on Monday after Friday's swift descent.
Jim Cramer breaks down how investors should be looking at Johnson & Johnson.
I find a lot of Reuters' claims hard to believe. Even more difficult to believe is the selloff.
Jim discusses Johnson & Johnson, Goldman Sachs, CVS Health and more!
Many analysts advise buying the shares on weakness because it's attractively priced.
JNJ ended the day and week in a vulnerable position and we are seeing further weakness today.
Jim Cramer breaks down what you need to know about the markets as Monday trading kicks off.
A trader can not risk buying the name here outright unless one is certain on a lot of items that are currently unknown.
Global stocks drifted lower Monday, pushing U.S. equity futures heading into red at the start of what is likely the final full trading week of the year, as investors remain cautious over the health of the world economy and remain focused on two key policy events in the coming days.
The market appears to still be spooked by JNJ as shares are set to open at their lowest level since July amid the Reuters articles fallout.
Now the unnerving thing about this market is that when it gets on a negative roll it blows through all convention.
While headline-chasing algorithms alter expected outcomes based on fundamental analysis, technical analysis remains valid.
U.S. stock futures are lower Monday as investors remain cautious over the health of the world economy and look to the Federal Reserve's decision on interest rates Wednesday; officials in Malaysia file criminal charges against Goldman Sachs related to the 1MDB scandal; Nissan's board is meeting Monday to pick a chairman to replace Carlos Ghosn, who was arrested on charges of financial misconduct.
It's a brutal market these days, but bargains are being created, Jim Cramer told Mad Money viewers Friday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.